GreenMark Biomedical
East Lansing, US · Founded 2016 · Delaware corporation · 3 known investors
Founders & leadership
GreenMark Biomedical was founded in 2016 by Steven Bloembergen, PhD.
SB
Steven Bloembergen, PhDFounder
SB
Steven BloembergenNamed on SEC filing
Board
MS
Michael SnyderBoard director
JL
Joerg Lahann, Ph.D.Board director
KP
Kenneth PientaBoard director
FV
Frank van LuttikhuizenBoard director
Investors · 3
Reported raises · per SEC filings
Form D private placements$1.7M disclosed across 2 of 5 rounds · 2018–2026
▶$5MofferedApr 2026 · BiotechnologyRule 506(b)
▶$5MofferedApr 2026 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Steven Bloembergen PhDExecutive Officer, Director
- Michael SnyderDirector
- Joerg Lahann, PhDDirector
- Offering amount
- $5M
- Minimum investment
- $25K
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$500KofferedJan 2025 · BiotechnologyRule 506(b)
▶$500KofferedJan 2025 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael SnyderDirector
- Steven Bloembergen, PhDExecutive Officer, Director
- Joerg Lahann, Ph.D.Director
- Offering amount
- $500K
- Minimum investment
- $10K
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$500KraisedOct 2022 · 3 investors · BiotechnologyRule 506(b)
▶$500KraisedOct 2022 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Joerg Lahann, Ph.D.Director
- Jeff WesleyDirector
- Frank van LuttikhuizenDirector
- Steven BloembergenExecutive Officer, Director
- Michael SnyderDirector
- Offering amount
- $1M
- Amount sold
- $500K
- Minimum investment
- $30K
- First sale
- Oct 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2MofferedJul 2020 · BiotechnologyRule 506(b)
▶$2MofferedJul 2020 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael SnyderDirector
- Joerg LaHann, Ph.D.Director
- Steven BloembergenExecutive Officer, Director
- Kenneth PientaDirector
- Frank van LuttikhuizenDirector
- Offering amount
- $2M
- Minimum investment
- $25K
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$1.2MraisedMar 2019 · BiotechnologyRule 506(b)
▶$1.2MraisedMar 2019 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Frank van Luttikhuizen, CPADirector
- Joerg LaHann, Ph.D.Director
- Michael D. SnyderDirector
- Kenneth Pienta, M.D.Director
- Steven Bloembergen, Ph.D.Executive Officer, Director
- Offering amount
- $1.2M
- Amount sold
- $1.2M
- Minimum investment
- $25K
- First sale
- May 2018
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 1
by search overlap
Companies competing with GreenMark Biomedical for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2019 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $228.9K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- Who founded GreenMark Biomedical?
- GreenMark Biomedical was founded by Steven Bloembergen, PhD in 2016.
- Who are GreenMark Biomedical's investors?
- GreenMark Biomedical's investors include ID Ventures, Invest Michigan, Michigan Rise.
- How much funding has GreenMark Biomedical raised?
- GreenMark Biomedical has disclosed $1.7M raised across 2 of its 5 known rounds.
- Where is GreenMark Biomedical headquartered?
- GreenMark Biomedical is headquartered in East Lansing, US.